ML22175A039

Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility

ML22175A039
Person / Time
Site:	SHINE Medical Technologies
Issue date:	07/11/2022
From:	Tanya Smith NRC/NMSS/DREFS/ELRB
To:	Nelson R - No Known Affiliation
Rakovan L, NMSS/DREFS/ERMB
Shared Package
ML22165A189	List: ML22175A039 ML22175A054 ML22175A063 ML22175A074 ML22175A077 ML22175A091
References
Download: ML22175A039 (4)

Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 Reid Nelson, Director Office of Federal Agency Programs Advisory Council on Historic Preservation 401 F Street NW, Suite 308 Washington, DC 20001-2637

SUBJECT:

NOTICE OF AVAILABILITY AND REQUEST FOR COMMENTS ON DRAFT ENVIRONMENTAL IMPACT STATEMENT SUPPLEMENT RELATED TO THE OPERATING LICENSE FOR THE SHINE MEDICAL ISOTOPE PRODUCTION FACILITY (DOCKET NO. 50-608)

Dear Reid Nelson:

The U.S. Nuclear Regulatory Commission (NRC) is conducting an environmental review of an application for an operating license from SHINE Medical Technologies, LLC (SHINE) for a medical isotope production facility (the SHINE facility). The operating license application was submitted pursuant to Title 10 of the Code of Federal Regulations (10 CFR) part 50.

The SHINE facility is being constructed approximately 4 miles south of Janesville, Rock County, Wisconsin and if licensed, would produce radioisotopes for use in diagnostic medical procedures.

As stated in our letter dated November 27, 2019, a review was conducted for the construction permit application for the SHINE facility from 2013-2015. At the conclusion of the safety and environmental reviews, the NRC issued Construction Permit No. CPMIF-001 for the SHINE facility to SHINE on February 29, 2016 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML16041A473). The safety review was supported by NUREG-2189, Safety Evaluation Report Related to SHINE Medical Technologies, Inc. Construction Permit Application for a Medical Radioisotope Production Facility, dated August 2016 (ML16229A140), and the environmental review was supported by NUREG-2183, Environmental Impact Statement for the Construction Permit for the SHINE Medical Radioisotope Production Facility, dated October 2015 (ML15288A046).

In connection with the issuance of an operating license for a production or utilization facility, the NRC is required to supplement its final Environmental Impact Statement (EIS) on the construction permit for that facility in accordance with 10 CFR 51.95(b). This supplement updates the prior environmental review and will only cover matters that differ from those or that reflect significant new information relative to that discussed in the final EIS. Therefore, the NRC has prepared a draft Supplement 1 to NUREG-2183 (the draft supplement) under 10 CFR Part 51, the NRCs regulations implementing the National Environmental Policy Act of 1969, as amended (NEPA). July 8, 2022 R. Nelson 2

As discussed in our November 2019 letter, the NRC is complying with section 106 of the National Historic Preservation Act of 1966, as amended (NHPA), through the NEPA process in accordance with 36 CFR 800.8(c). Consistent with the area of potential effects (APE) previously considered for the construction permit application, the APE for this undertaking is the same (i.e., the area of the site and its immediate environs). In the context of NEPA, the NRC staffs preliminary determination is that the impacts on historic and cultural resources from the operation of the SHINE facility would remain small. Under the provisions of the NHPA, the NRC staffs preliminary determination is that no historic properties would be affected by this undertaking. This recommendation is based on: (1) the analysis and findings in the draft supplement; (2) consultation with Federal, State, Tribal, and local agencies; (3) the environmental report submitted by SHINE; (4) the NRC staffs independent environmental review; and (5) the consideration of public comments.

A copy of the draft supplement is available via the following link:

https://www.nrc.gov/docs/ML2217/ML22179A346.pdf. The draft supplement is also available through the web-based version of the NRCs ADAMS at https://www.nrc.gov/readingrm/adams.html under Accession No. ML22179A346.

Pursuant to 36 CFR 800.8(c), we are requesting your comments on the draft supplement and preliminary conclusions. Electronic comments may be submitted to the NRC by accessing https://www.regulations.gov and searching for Docket ID NRC-2022-0135 or by emailing SHINEEnvironmental@nrc.gov. Written comments should be submitted by mail to:

Program Management, Announcements and Editing Staff Office of Administration Mail Stop: TWFN-7A60M U.S. Nuclear Regulatory Commission Washington, DC 20555-0001

Please note that the public comment period for the draft supplement ends on August 22, 2022.

The NRC will hold a public meeting as an online webinar and teleconference to discuss the findings of the draft supplement on July 27, 2022, from 6:00 p.m. to 8:00 p.m. central time.

Webinar and teleconference details are available in the following NRC public meeting notice: https://www.nrc.gov/pmns/mtg?do=details&Code=20220659.

If you have any questions concerning the NRC staff's review of this operating license application, please contact Lance Rakovan, Senior Environmental Project Manager, at 301-415-2589 or via email at Lance.Rakovan@nrc.gov.

Sincerely, Theodore B. Smith, Chief Environmental Review License Renewal Branch Division of Rulemaking, Environmental, and Financial Support Office of Nuclear Material Safety and Safeguards Docket No. 50-608 Signed by Smith, Theodore on 07/08/22

ML22175A039 OFFICE NMSS/REFS/ELRBNMSS/REFS:LA NMSS/REFS/ELRB NAME LRakovan AWalker-Smith TSmith DATE 6/13/2022 6/13/2022 7/8/2022